Clinical Trials Directory

Trials / Completed

CompletedNCT02125019

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Longitudinal Evaluation of Taxane induced neuropathy in early stage breast cancer.

Detailed description

A study assessing the feasibility of evaluating neuropathy symptoms prospectively using testing of gate and balance parameters.

Conditions

Timeline

Start date
2013-12-04
Primary completion
2018-05-14
Completion
2018-05-14
First posted
2014-04-29
Last updated
2023-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02125019. Inclusion in this directory is not an endorsement.

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer (NCT02125019) · Clinical Trials Directory